.png){kind=icon}
.png){kind=icon}
Return
ADAM17 as a Therapeutic Target for the Treatment of Breast Cancer: Preclinical Studies with an Inhibitory Monoclonal Antibody
.png){kind=icon}
PRE
AI
DOI：10.1016/S0959-8049(12)72324-9.png)
.png){kind=icon}
Original request for help.png){kind=icon}
Share.png){kind=icon}
Save
Abstract
En
AI Summary
Key information extracted from the uploaded paper, including a brief overview, abstract, background, key highlights, visual analysis, and future outlook.
Journal
IF:
7.1
Papers:
2.6W
Citations:
3.8W